Co-Authors
This is a "connection" page, showing publications co-authored by Fu-Sheng Wang and Jinwen Song.
Connection Strength
1.513
-
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2021 02 10; 6(1):58.
Score: 0.232
-
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 2020 08 27; 5(1):172.
Score: 0.225
-
Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020 09; 21(9):1107-1118.
Score: 0.224
-
Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020 07 08; 11(1):3410.
Score: 0.223
-
Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020 08 04; 32(2):188-202.e5.
Score: 0.222
-
Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 04; 8(4):420-422.
Score: 0.217
-
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat Metab. 2021 07; 3(7):909-922.
Score: 0.060
-
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020 11; 27(11):3196-3207.
Score: 0.055
-
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
Score: 0.055